Fulgent Genetics Inc FLGT

NAS: FLGT | ISIN: US3596641098   30/04/2025
17,35 USD (-4,30%)
(-4,30%)   30/04/2025

9 februari 2024 · Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing · Persbericht

11 april 2023 · Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical Research · Persbericht

18 november 2022 · Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit · Persbericht

11 november 2022 · FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit · Persbericht

10 november 2022 · Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. · Persbericht

23 oktober 2022 · FLGT Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

17 oktober 2022 · FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit · Persbericht

15 oktober 2022 · FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT · Persbericht

14 oktober 2022 · Attention Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. and Encourages Investors to Contact the Firm · Persbericht

4 oktober 2022 · Kessler Topaz Meltzer & Check, LLP Reminds Fulgent Genetics, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

1 oktober 2022 · FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT · Persbericht

26 september 2022 · INVESTOR DEADLINE: Investors in Fulgent Genetics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FLGT · Persbericht

25 september 2022 · Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. · Persbericht

23 september 2022 · FLGT INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm's Attorneys, Securities Fraud Class Action Filed · Persbericht

5 juli 2022 · The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test · Persbericht

27 april 2022 · Avista Capital Partners Completes Sale Of Inform Diagnostics To Fulgent Genetics, Inc. · Persbericht

7 maart 2022 · Helio Health Announces Publication of ENCORE Data in Hepatology Communications, Demonstrating Superior Performance of HelioLiver for Early Detection of Liver Cancer · Persbericht

24 februari 2022 · EPIC SCIENCES AND FULGENT GENETICS COLLABORATE TO DELIVER DefineMBC™ RESULTS FOR METASTATIC BREAST CANCER PATIENTS · Persbericht

8 november 2021 · Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection · Persbericht

1 november 2021 · Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021 · Persbericht

Mijn selecties